S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
NASDAQ:GRCL

Gracell Biotechnologies - GRCL Short Interest Ratio & Short Volume

$2.11
-0.02 (-0.94%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.09
$2.54
50-Day Range
$2.01
$3.45
52-Week Range
$1.68
$5.69
Volume
9.59 million shs
Average Volume
150,757 shs
Market Capitalization
$142.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.20

Gracell Biotechnologies Short Interest Data

Current Short Volume
128,000 shares
Previous Short Volume
166,600 shares
Change Vs. Previous Month
-23.17%
Dollar Volume Sold Short
$285,440.00
Short Interest Ratio / Days to Cover
1.0
Last Record Date
January 15, 2023
Outstanding Shares
67,680,000 shares
Float Size
55,950,000 shares
Short Percent of Float
0.23%
Today's Trading Volume
9,585,042 shares
Average Trading Volume
150,757 shares
Today's Volume Vs. Average
6,257.95%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Gracell Biotechnologies ?

Sign up to receive the latest short interest report for Gracell Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GRCL Short Interest Over Time

GRCL Days to Cover Over Time

GRCL Percentage of Float Shorted Over Time

Gracell Biotechnologies (NASDAQ:GRCL) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/2023128,000 shares $285,440.00 -23.2%0.2%1 $2.23
12/30/2022166,600 shares $383,180.00 -27.6%0.3%1.7 $2.30
12/15/2022230,200 shares $580,104.00 +49.0%0.4%2.5 $2.52
11/30/2022154,500 shares $502,125.00 -18.4%0.3%3.5 $3.25
11/15/2022189,300 shares $702,303.00 -41.7%0.3%4 $3.71
10/31/2022324,800 shares $1.04 million +31.1%0.6%5.9 $3.19
10/15/2022247,700 shares $745,577.00 -5.7%0.4%4.1 $3.01
9/30/2022262,600 shares $845,572.00 +29.8%0.5%4 $3.22
9/15/2022202,300 shares $445,060.00 -27.8%0.4%2.3 $2.20
8/31/2022280,200 shares $703,302.00 -7.3%0.5%3 $2.51
8/15/2022302,400 shares $1.02 million -53.0%0.5%2.7 $3.38
7/31/2022643,400 shares $2.27 million +2.6%1.1%5.3 $3.53
7/15/2022627,300 shares $2.57 million -46.8%1.1%5.2 $4.10
6/30/20221,180,000 shares $6.49 million +2.6%2.1%8.4 $5.50
6/15/20221,150,000 shares $4.27 million +43.4%2.0%6.4 $3.71
5/31/2022802,000 shares $2.64 million +38.6%1.4%3.8 $3.29
5/15/2022578,600 shares $1.93 million -5.1%1.0%2.8 $3.33
4/30/2022609,600 shares $1.37 million -3.8%1.1%2.5 $2.25
4/15/2022633,700 shares $1.31 million -41.3%1.2%2.1 $2.06
3/31/20221,080,000 shares $2.52 million -10.7%N/A0 $2.33
3/15/20221,210,000 shares $2.36 million +2.5%2.2%4.6 $1.95
2/28/20221,180,000 shares $3.76 million +12.4%2.1%4.4 $3.19
2/15/20221,050,000 shares $4.11 million +1.0%1.8%1.8 $3.91
1/31/20221,040,000 shares $3.69 million -14.8%2.9%1.6 $3.55
1/15/20221,220,000 shares $5.60 million -8.3%N/A2.1 $4.59
12/31/20211,330,000 shares $8.03 million +3.9%2.3%2.4 $6.04
12/15/20211,280,000 shares $7.99 million +11.3%2.2%2.4 $6.24
11/30/20211,150,000 shares $8.90 million +71.0%2.0%2.3 $7.74
11/15/2021672,600 shares $7.34 million +6.1%1.2%1.5 $10.92
10/29/2021634,200 shares $6.79 million -23.0%1.1%7.8 $10.70
10/15/2021823,400 shares $10.90 million -25.2%1.4%10.1 $13.24
9/30/20211,100,000 shares $15.26 million -3.5%1.9%14.5 $13.87
9/15/20211,140,000 shares $16.92 million -5.0%2.0%12.6 $14.84
8/31/20211,200,000 shares $12.52 million -10.5%2.1%11.8 $10.43
8/13/20211,340,000 shares $15.53 million No Change2.3%10.7 $11.59













GRCL Short Interest - Frequently Asked Questions

What is Gracell Biotechnologies' current short interest?

Short interest is the volume of Gracell Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 128,000 shares of GRCL short. 0.23% of Gracell Biotechnologies' shares are currently sold short. Learn More on Gracell Biotechnologies' current short interest.

What is a good short interest ratio for Gracell Biotechnologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRCL shares currently have a short interest ratio of 1.0. Learn More on Gracell Biotechnologies's short interest ratio.

What is a good short interest percentage for Gracell Biotechnologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.23% of Gracell Biotechnologies' floating shares are currently sold short.

Is Gracell Biotechnologies' short interest increasing or decreasing?

Gracell Biotechnologies saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 128,000 shares, a decline of 23.2% from the previous total of 166,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Gracell Biotechnologies' float size?

Gracell Biotechnologies currently has issued a total of 67,680,000 shares. Some of Gracell Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gracell Biotechnologies currently has a public float of 55,950,000 shares.

How does Gracell Biotechnologies' short interest compare to its competitors?

0.23% of Gracell Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Gracell Biotechnologies: Cue Biopharma, Inc. (1.50%), Annovis Bio, Inc. (3.44%), Nanobiotix S.A. (0.00%), OptiNose, Inc. (3.30%), DURECT Co. (1.43%), Alaunos Therapeutics, Inc. (11.08%), VBI Vaccines Inc. (4.95%), Trevi Therapeutics, Inc. (0.16%), Anixa Biosciences, Inc. (2.01%), and Nuvectis Pharma, Inc. (0.66%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short Gracell Biotechnologies stock?

Short selling GRCL is an investing strategy that aims to generate trading profit from Gracell Biotechnologies as its price is falling. GRCL shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gracell Biotechnologies?

A short squeeze for Gracell Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRCL, which in turn drives the price of the stock up even further.

How often is Gracell Biotechnologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRCL, twice per month. The most recent reporting period available is January, 15 2023.



This page (NASDAQ:GRCL) was last updated on 2/5/2023 by MarketBeat.com Staff